Study Overview: This research study is testing new flu vaccines, specifically A/H5 influenza, to see if they are safe and if they work well at different doses. The study uses special ingredients called "adjuvants" (AS03 and MF59) to help the vaccine work better. It's organized so neither the doctors nor the participants know who gets which vaccine or dose, making it a "double-blind" study.
Key Medical Terms:- Randomized: Participants are placed into groups by chance, like flipping a coin.
- Double-blind: Neither the participants nor the researchers know who is getting which treatment.
- Immunogenicity: The ability of the vaccine to trigger an immune response.
Participation Details:
- The study lasts about 203 days with several visits required.
- Vaccines are given twice, 21 days apart.
- Participants must be healthy adults over 18 and not pregnant.
Considerations: Potential participants should ensure they can attend all visits and follow all instructions. The study is looking for people in stable health and not planning to move away during the study period.
How understandable was the trial content above?
Hard to understand
Easy to understand